Steep Dose–Response Relationship for Stage I Non–Small-Cell Lung Cancer Using Hypofractionated High-Dose Irradiation by Real-Time Tumor-Tracking Radiotherapy
- 1 February 2008
- journal article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 70 (2) , 374-381
- https://doi.org/10.1016/j.ijrobp.2007.06.043
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Stereotactic body radiation therapy for nonmetastatic lung cancer: An analysis of 75 patients treated over 5 yearsInternational Journal of Radiation Oncology*Biology*Physics, 2006
- Speed and amplitude of lung tumor motion precisely detected in four-dimensional setup and in real-time tumor-tracking radiotherapyInternational Journal of Radiation Oncology*Biology*Physics, 2006
- Stereotactic hypofractionated radiotherapy for stage I non-small cell lung cancer—Mature results for medically inoperable patientsLung Cancer, 2006
- Accreditation and quality assurance for Radiation Therapy Oncology Group: Multicenter clinical trials using Stereotactic Body Radiation Therapy in lung cancerActa Oncologica, 2006
- A challenge to traditional radiation oncologyInternational Journal of Radiation Oncology*Biology*Physics, 2004
- Stereotactic hypofractionated high‐dose irradiation for stage I nonsmall cell lung carcinomaCancer, 2004
- Stereotactic single-dose radiotherapy of stage I non–small-cell lung cancer (NSCLC)International Journal of Radiation Oncology*Biology*Physics, 2003
- Real‐time tumor‐tracking radiation therapy for lung carcinoma by the aid of insertion of a gold marker using bronchofiberscopyCancer, 2002
- Estimation of tumor control probability model parameters from 3-D dose distributions of non-small cell lung cancer patientsLung Cancer, 1999
- Radiotherapy for patients with medically inoperable stage I nonsmall cell lung carcinomaCancer, 1998